Cargando…
A Case of Subacute Thyroiditis following COVID-19 Infection
Background/Objective. Since the start of the pandemic, COVID-19 has been associated with several postinfection complications. Subacute thyroiditis (SAT) is an inflammatory disorder of the thyroid that has been reported in the literature following COVID-19 infection. We report a case of SAT following...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9174011/ https://www.ncbi.nlm.nih.gov/pubmed/35685291 http://dx.doi.org/10.1155/2022/2211061 |
_version_ | 1784722146123055104 |
---|---|
author | Elawady, Sameh Samir Phuyal, Diwakar Shah, Rakesh Kumar Mirza, Lubna |
author_facet | Elawady, Sameh Samir Phuyal, Diwakar Shah, Rakesh Kumar Mirza, Lubna |
author_sort | Elawady, Sameh Samir |
collection | PubMed |
description | Background/Objective. Since the start of the pandemic, COVID-19 has been associated with several postinfection complications. Subacute thyroiditis (SAT) is an inflammatory disorder of the thyroid that has been reported in the literature following COVID-19 infection. We report a case of SAT following COVID-19 infection. Case Report. A 33-year-old female presented with neck pain two weeks after resolution of COVID-19 infection. Her thyroid function tests together with ultrasonographic pictures were consistent with SAT. She was treated with three rounds of medrol dose pack without relief. She then required oral prednisone 40 mg per day and ibuprofen 800 mg once daily for another several weeks that eventually resulted in improvement of her symptoms. Discussion. SAT most commonly occurs in females during or after viral infection. The usual course of the disease is hyperthyroidism then hypothyroidism followed by resolution. SAT is clinically diagnosed by lab findings of decreased TSH in the setting of negative thyroid-stimulating and thyroid peroxidase antibodies. All these data are consistent with our case. Conclusion. SAT following COVID-19 infection presents with a similar clinical presentation and course as the classic form of SAT, but we should consider the fact that a high-dose corticosteroid treatment might be necessary for such patients. |
format | Online Article Text |
id | pubmed-9174011 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Hindawi |
record_format | MEDLINE/PubMed |
spelling | pubmed-91740112022-06-08 A Case of Subacute Thyroiditis following COVID-19 Infection Elawady, Sameh Samir Phuyal, Diwakar Shah, Rakesh Kumar Mirza, Lubna Case Rep Endocrinol Case Report Background/Objective. Since the start of the pandemic, COVID-19 has been associated with several postinfection complications. Subacute thyroiditis (SAT) is an inflammatory disorder of the thyroid that has been reported in the literature following COVID-19 infection. We report a case of SAT following COVID-19 infection. Case Report. A 33-year-old female presented with neck pain two weeks after resolution of COVID-19 infection. Her thyroid function tests together with ultrasonographic pictures were consistent with SAT. She was treated with three rounds of medrol dose pack without relief. She then required oral prednisone 40 mg per day and ibuprofen 800 mg once daily for another several weeks that eventually resulted in improvement of her symptoms. Discussion. SAT most commonly occurs in females during or after viral infection. The usual course of the disease is hyperthyroidism then hypothyroidism followed by resolution. SAT is clinically diagnosed by lab findings of decreased TSH in the setting of negative thyroid-stimulating and thyroid peroxidase antibodies. All these data are consistent with our case. Conclusion. SAT following COVID-19 infection presents with a similar clinical presentation and course as the classic form of SAT, but we should consider the fact that a high-dose corticosteroid treatment might be necessary for such patients. Hindawi 2022-05-31 /pmc/articles/PMC9174011/ /pubmed/35685291 http://dx.doi.org/10.1155/2022/2211061 Text en Copyright © 2022 Sameh Samir Elawady et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Case Report Elawady, Sameh Samir Phuyal, Diwakar Shah, Rakesh Kumar Mirza, Lubna A Case of Subacute Thyroiditis following COVID-19 Infection |
title | A Case of Subacute Thyroiditis following COVID-19 Infection |
title_full | A Case of Subacute Thyroiditis following COVID-19 Infection |
title_fullStr | A Case of Subacute Thyroiditis following COVID-19 Infection |
title_full_unstemmed | A Case of Subacute Thyroiditis following COVID-19 Infection |
title_short | A Case of Subacute Thyroiditis following COVID-19 Infection |
title_sort | case of subacute thyroiditis following covid-19 infection |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9174011/ https://www.ncbi.nlm.nih.gov/pubmed/35685291 http://dx.doi.org/10.1155/2022/2211061 |
work_keys_str_mv | AT elawadysamehsamir acaseofsubacutethyroiditisfollowingcovid19infection AT phuyaldiwakar acaseofsubacutethyroiditisfollowingcovid19infection AT shahrakeshkumar acaseofsubacutethyroiditisfollowingcovid19infection AT mirzalubna acaseofsubacutethyroiditisfollowingcovid19infection AT elawadysamehsamir caseofsubacutethyroiditisfollowingcovid19infection AT phuyaldiwakar caseofsubacutethyroiditisfollowingcovid19infection AT shahrakeshkumar caseofsubacutethyroiditisfollowingcovid19infection AT mirzalubna caseofsubacutethyroiditisfollowingcovid19infection |